» Articles » PMID: 33762957

Beyond Alkaloids: Novel Bioactive Natural Products From Species

Overview
Journal Front Pharmacol
Date 2021 Mar 25
PMID 33762957
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In this work, we reviewed the progress in the phytochemical and biological investigations of bioactive components derived from medicinally valuable species. In the last 60 years, has garnered significant attention from the phytochemist from around the world, majorly due to the discovery of bioactive piperidine alkaloids (e.g., lobinaline and lobeline) in the early 1950s. Later, lobeline underwent clinical trials for several indications including the treatment of attention deficit hyperactivity disorder and a multicenter phase three trial for smoking cessation. Subsequently, several other alkaloids derived from different species of were also investigated for their pharmacological characteristics. However, in the last few years, the research focus has started shifting to the characterization of the other novel chemical classes. The major shift has been noticed due to the structurally similar alkaloid components, which essentially share similar pharmacological, physicochemical, and toxicological profiles. In this review, we present an up-to-date overview of their progress with special attention to understanding the molecular mechanisms of the novel bioactive components.

Citing Articles

A Plant Model of -Synucleinopathy: Expression of -Synuclein A53T Variant in Hairy Root Cultures Leads to Proteostatic Stress and Dysregulation of Iron Metabolism.

Kurepa J, Bruce K, Gerhardt G, Smalle J Appl Biosci (Basel). 2024; 3(2):233-249.

PMID: 38835931 PMC: 11149894. DOI: 10.3390/applbiosci3020016.


LC-ESI-MS/MS-Based Comparative Metabolomic Study, Antioxidant and Antidiabetic Activities of Three Lobelia Species: Molecular Modeling and ADMET Study.

Elkhawas Y, Gad H, AbdelRazek M, Mandour A, Bishr M, Al Musayeib N ACS Omega. 2024; 9(18):20477-20487.

PMID: 38737064 PMC: 11079896. DOI: 10.1021/acsomega.4c01587.


Plastome evolution in the East Asian lobelias (Lobelioideae) using phylogenomic and comparative analyses.

Li C, Xie X, Liu H, Wang R, Li D Front Plant Sci. 2023; 14:1144406.

PMID: 37063184 PMC: 10102522. DOI: 10.3389/fpls.2023.1144406.


From -Lobeline to -Lobeline: Study on the Pharmacodynamics and Isomerization Factors.

Xu H, Yang L, Tang M, Ye A, Tu B, Jiang Z Molecules. 2022; 27(19).

PMID: 36234790 PMC: 9573392. DOI: 10.3390/molecules27196253.

References
1.
Gedeon J, Gedeon S . [Alkaloids of Lobella nicotianaefolia Heyne]. Pharm Acta Helv. 1954; 29(2):49-52. View

2.
SALDANHA R, Cordeiro E, Costa E, de MELO . Study of circulatory rate with lobeline (the alkaloid from Lobelia inflata). Arq Bras Cardiol. 1959; 12:215-22. View

3.
Kesting J, Tolderlund I, Pedersen A, Witt M, Jaroszewski J, Staerk D . Piperidine and tetrahydropyridine alkaloids from Lobelia siphilitica and Hippobroma longiflora. J Nat Prod. 2009; 72(2):312-5. DOI: 10.1021/np800743w. View

4.
Yang S, Shen T, Zhao L, Li C, Zhang Y, Lou H . Chemical constituents of Lobelia chinensis. Fitoterapia. 2014; 93:168-74. DOI: 10.1016/j.fitote.2014.01.007. View

5.
Nickell J, Krishnamurthy S, Norrholm S, Deaciuc G, Siripurapu K, Zheng G . Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. J Pharmacol Exp Ther. 2009; 332(2):612-21. PMC: 2812121. DOI: 10.1124/jpet.109.160275. View